This application is a US National Phase application under 35 USC § 371 of PCT/CA2014/000660, filed Aug. 28, 2014, which in turn, claims priority and the benefit of Canadian patent application 2,826,516, filed Aug. 30, 2013, the specifications of which are hereby incorporated by reference in their entireties.
The subject matter disclosed generally relates to a flow measuring apparatus and inhalations apparatus for drug delivery by inhalation comprising the same.
Many drugs to treat diseases such as obstructive pulmonary disease, asthma, bronchial, or the bronchiolitis, are administered by inhalation for example by means of metered dose inhalers (MDI). The inhaler uses a propellant which generates an aerosol of the substance drug or active substance.
Inhalation devices (or apparatus) commonly used in inhalation treatments often needs an inhalation chamber. The use of an inhalation chamber has long been recognized to facilitate and improve the medication in a treatment by inhalation (aerotherapy), in particular for improving the distribution of therapeutic substances (medicament) in the bronchi and reduce deposits in the airways above, where they are responsible for side effects. Indeed, in the absence of such an inhalation chamber, the coordination between the activation of the inhaler and inspiration is paramount. However, this coordination is difficult to achieve for many patients, especially in children.
The inhalation chamber defines an internal volume in which the medicament is propelled by means of an opening made in one end of the opening chamber which is fitted on the source of the drug, for example a MDI. At another end of the inhalation chamber is another opening in communication with the patient's mouth through a connection means, generally a tubular part such as a mouthpiece that the patient may insert in his/her mouth directly. It is also possible to connect a face mask on the connection means, in particular in the case of devices for young children. The drug substance is propelled as a gas in the inhalation chamber for example by pressing the MDI. When the patient inhales through the mask or mouthpiece, the drug substance is transported into the lungs of the patient by an outflow from the inhalation chamber generated by the patient's inhalation.
However, it is not easy for the patient to verify that the inspiratory flow generated was efficient enough to inhale the full dose of drug substance or that the inhalation device works correctly. For example, if the inspiratory flow is too low or too strong, effective treatment may be compromised.
Inhalation devices including an inhalation chamber in which means of attesting to the good inhalation of the patient are known in the art. For example, there is an inhalation chamber in which a visible color means adjacent to an unidirectional inhalation valve moves according to the inspiratory flow. Such means provides a way to assess the passage of the inspiratory flow through the valve, however it does not measure the flow rate of inspiratory flow and eventually compare it to a reference value.
Therefore, it is an object of the present invention to provide a flow measuring apparatus which may be used for measuring the flow through a section of an inhalation apparatus. Also, it is an object of the present invention to provide an inhalation apparatus having a flow measuring apparatus for measuring flow through a section of the inhalation apparatus.
According to an embodiment, there is provided a flow measuring apparatus for measuring a flow through a section of an inhalation apparatus, comprising:
The first and the second Pitot tubes may be back to back.
The at least one opening facing a direction of the flow and the at least one opening facing a direction opposed to the flow are substantially coplanar along the longitudinal axis of the first and the second Pitot tubes.
The set of Pitot tubes may be streamlined, to reduce resistance of the set of Pitot tubes to the flow within the section of an inhalation apparatus.
The one of the first and the second Pitot tube may be for measuring a stagnation pressure, and the other of the first and the second Pitot tube may be for measuring a static pressure.
The first Pitot tube is for measuring a stagnation pressure, and the second Pitot tube may be for measuring a static pressure, or the first Pitot tube may be for measuring a static pressure, and the second Pitot tube is for measuring a stagnation pressure.
The flow measuring apparatus of any one of claims 1 to 4, wherein the at least one opening is a single opening, or two openings, or three openings, or four openings.
The at least one opening may be a circular opening, or a slot, or an oval opening, or a square opening, or a rectangular opening, or combinations thereof.
The at least one opening may be positioned along the longitudinal axis of the first or second Pitot tubes at regular intervals.
The flow measuring apparatus may further comprise a processor, operatively connected to the flow measuring apparatus, for calculating the flow rate from the difference between a stagnation pressure and a static pressure measured with the flow measuring apparatus.
The flow measuring apparatus may further comprise a transmission means for transmitting the flow rate.
The flow measuring apparatus may further comprise a visual means to visually indicate correct use of the flow measuring apparatus, the inhalation apparatus, or both.
The any one of the processor, the transmission means, and the visual means may be comprised within a housing.
The set of Pitot tubes may be removable.
According to another embodiment, there is provided an inhalation apparatus for drug delivery by inhalation comprising:
The second end may be a mouthpiece or a tube to be connected to a face mask.
The inhalation apparatus may further comprise a valve, downstream of the inhalation chamber and upstream of the second end, allowing passage of the flow from the inhalation chamber to the second end.
The valve may be a one-way inhalation valve.
The second end may further comprise an expiratory valve.
The second end may further comprise a tubular portion.
The tubular portion may comprise an expiratory valve.
The at least one set of Pitot tubes may be provided in the first end, or in the inhalation chamber, or in the second portion, or combinations thereof to measure the inhalation flow rate.
The at least one set of Pitot tubes may be provided in the tubular portion, or the expiratory valve, or combinations thereof to measure the expiratory flow rate.
The flow measuring apparatus may be removable.
The following terms are defined below.
The term “Pitot tube” is intended to mean a pressure measurement instrument used to measure fluid flow velocity. It is used to measure liquid, air and gas velocities in the present invention. The Pitot tube is used to measure the local velocity at a given point in the flow stream and not the average velocity in the pipe or conduit.
The term “dynamic pressure” is intended to mean the kinetic energy per unit volume of a fluid particle. In simplified cases, the dynamic pressure is equal to the difference between the stagnation pressure and the static pressure.
The term “static pressure” is intended to mean the pressure of a fluid particle on a body when the body is at rest relative to the fluid.
The term “stagnation pressure” is the static pressure at a stagnation point in a fluid flow. At a stagnation point the fluid velocity is zero and all kinetic energy has been converted into pressure energy (isentropically). Stagnation pressure is equal to the sum of the free-stream dynamic pressure and free-stream static pressure. Stagnation pressure is sometimes referred to as Pitot pressure because it is measured using a Pitot tube.
Features and advantages of the subject matter hereof will become more apparent in light of the following detailed description of selected embodiments, as illustrated in the accompanying figures. As will be realized, the subject matter disclosed and claimed is capable of modifications in various respects, all without departing from the scope of the claims. Accordingly, the drawings and the description are to be regarded as illustrative in nature, and not as restrictive and the full scope of the subject matter is set forth in the claims.
Further features and advantages of the present disclosure will become apparent from the following detailed description, taken in combination with the appended drawings, in which:
It will be noted that throughout the appended drawings, like features are identified by like reference numerals.
Referring now to the drawings, and more particularly to
Now referring to
The Reynolds number
is defined with the flow velocity U0. As a function of the increase of this dimensionless number, the organization of the flow changes dramatically.
Low Renolds numbers correspond to flow that is completely “laminar” while fully “turbulent” flows (
Other variations are discussed in the literature: the case of cylinders of small aspect ratio (short cylinders); the case where the cylinder does not cover the entire length of the test section, at the end of the cylinder, the organization of the flow becomes three-dimensional flow; and the case of tandem cylinders, where a second cylinder is placed farther downstream in the wake of the first, the organization of the flow becomes highly complex (
Without wishing to be bound by theory, independently of the shape of the cross sections of the cylinders, they generate a wake. According to an embodiment of the present invention, the configuration of the flow measuring apparatus 10 of the present invention with a set of Pitot tubes 20 having a streamlined profile (e.g. having a section close to an oval shape), traversing the entire width of the conduit (the lumen of the conduit), results in principle in a flow having an organization likely to be at least two-dimensional on the central portion of the conduit. This therefore improves the precision and the reproducibility of the measurements, especially in situations where the flow is low.
According to an embodiment, the set of Pitot tubes 20 may comprise first and second Pitot tubes 21, 22 which are contacting each other along the longitudinal axis to eliminate any gap between the first and second Pitot tubes 21, 22. Now referring to
One of the Pitot tubes of the set 20 is a tube measuring stagnation pressure (e.g. first Pitot tube 21), the other is a measuring tube for static pressure (e.g. second Pitot tube 22). Each Pitot tube has at least one opening, such as opening 100. These openings allow the measurement of a mean stagnation pressure and a mean static pressure during the passage of a flow through the openings. Thus, according to an embodiment, the first and second Pitot tubes 21, 22 may comprise at least one opening 100 facing a direction of the flow (F). The at least one 100 opening may be a single, longitudinal opening slot, as shown in
According to another embodiment, the set of Pitot tubes 20 is configured for traversing entirely the lumen (L) of the section of an inhalation apparatus 200, as shown in
According to another embodiment, the set of Pitot tubes 20 may be streamlined in order to reduce the resistance of the set of Pitot tubes 20 to the flow within the section of an inhalation apparatus 200. According to an embodiment, the first and second Pitot tubes 21, 22 may be shaped so as to present a generally streamlined configuration when in contact with one another. For example, the first and second Pitot tubes 21, 22 may be shaped as half-circles, or half-ovals providing a substantially circular or oval shape to the set of Pitot tubes 20 when in contact with one another. According to another embodiment, the region (R) of the set of Pitot tubes 20 where the first and second Pitot tubes 21, 22 are in contact with one another may be filled with an appropriate material that is shaped or molded so as to provide a generally streamlined profiled (
According to another embodiment, the first and second Pitot tube 21, 22 are respectively fluidly connected to a differential pressure sensor 324, for measuring a difference between a stagnation pressure and a static pressure within the flow measuring apparatus 10.
The first and second Pitot tubes 21, 22 may be connected to the differential pressure sensor 324 through connecting means 325 and 326. According to another embodiment, the flow measuring apparatus 10 may also include a processor 327, for calculating the flow from the difference between a stagnation pressure and a static pressure measured with the flow measuring apparatus 10. The processor 327 may transmit a flow rate signal through transmission means 328 and/or a activate visual means 329, such as a light emitting diode, or a display, indicating the correct use of an inhalation apparatus, such as apparatus 200. The operation of these elements is described in
The differential pressure sensor 324, the processor 327, the transmission means 328 and visual means 329 may be contained within a single housing 330 (
According to another embodiment, portions of the inhalation apparatus 200 may be removable, for example to be cleaned or to be replaceable by fresh part.
The same flow measuring apparatus 10 can comprise more than one sets of Pitot tubes 20. For example, a set of Pitot tubes 20 may be provided in the first end 312 of an inhalation apparatus 200 in order to measure the inhalation flow rate (
According to another embodiment, a flow measuring apparatus 10 of the present invention may be provided in an inhalation apparatus 200 without inspiratory or expiratory valves.
Now referring to
In a second embodiment there is disclosed an inhalation apparatus 200 for drug delivery by inhalation comprising:
According to the second embodiment, the inhalation chamber 310 having a first end 312 to be connected to a source of drug is intended to be the source of drug (in other words medicinal substances or medicaments) such as a spray inhaler or metered dose inhaler (MDI), and a second end 314, such as a connecting portion to be connected to the a user. This allows the communication between the inhalation chamber 310 of the inhalation apparatus 200 and thus a user. According to an embodiment, second end 314, such as the connecting portion may be either a mouthpiece or a tube that may be connected to a face mask.
According to another embodiment, the inhalation apparatus 200 may comprise a valve 316, for example a duckbill valve may be provided upstream of the user relative to the chamber 310. Any suitable valve may be used in the inhalation apparatus of the present invention. According to an embodiment, this valve 316 is preferably a one-way inhalation valve allowing the passage of a flow carrying the drug particles from the interior of the chamber 310 towards the connecting portion of the second end 314 and the user during the inhalation phase generated by the user.
According to another embodiment, the second end 314 may also comprises a tubular portion 318, having an expiratory valve 320. Preferably, the expiratory valve 320 is a unidirectional valve. The expiratory valve 320 permits the passage of the air flow generated by the user during an expiration phase to an outlet 322 included in the tubular portion 318.
The inhalation apparatus 200 includes a flow measuring apparatus 10 of the present invention, traversing entirely a lumen of a section of the inhalation apparatus 200, for measuring flow of the drug within the section of the inhalation apparatus 200. The flow measuring apparatus 10 as described above may be arranged in the path of flow in the second end 314 downstream of the valve 316 (
The first and second Pitot tubes 21, 22 may be connected to the differential pressure sensor 324 through connecting means 325 and 326. According to another embodiment, the flow measuring apparatus 10 may also include a processor 327, for calculating the flow from the difference between a stagnation pressure and a static pressure measured with the flow measuring apparatus 10. The processor 327 may transmit a flow rate signal 328 and/or a activate visual means 329, such as a light emitting diode, indicating the correct use of an inhalation apparatus, such as apparatus 200. The operation of these elements is described in
Now referring to
The inhalation apparatus 200 may comprise a flow measuring apparatus 10 having more than one set of Pitot tubes 20. For example, a set of Pitot tubes 20 may be provided in the first end 312 of an inhalation apparatus 200 in order to measure the inhalation flow rate, and another set of Pitot tubes 20 may be provided in the tubular portion 318 that contains the expiratory valve 320 to measure the rate of expiratory flow. Also, more than one set of Pitot tubes 20 may be included in any one section of the inhalation apparatus.
According to another embodiment, a flow measuring apparatus 10 of the present invention may be provided in an inhalation apparatus 200 without inspiratory or expiratory valves.
While preferred embodiments have been described above and illustrated in the accompanying drawings, it will be evident to those skilled in the art that modifications may be made without departing from this disclosure. Such modifications are considered as possible variants comprised in the scope of the disclosure.
Number | Date | Country | Kind |
---|---|---|---|
2826516 | Aug 2013 | CA | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CA2014/000660 | 8/28/2014 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/027326 | 3/5/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2270540 | Mallory | Jan 1942 | A |
3045666 | Dubsky | Jul 1962 | A |
4154100 | Harbaugh | May 1979 | A |
4453419 | Engelke | Jun 1984 | A |
4592239 | Cutler | Jun 1986 | A |
4624146 | Nakagawa | Nov 1986 | A |
4645242 | Coleman | Feb 1987 | A |
4703661 | Evers | Nov 1987 | A |
4717159 | Alston | Jan 1988 | A |
5036711 | Good | Aug 1991 | A |
5038773 | Norlien | Aug 1991 | A |
5088332 | Merilainen | Feb 1992 | A |
5111827 | Rantala | May 1992 | A |
5123288 | Tench | Jun 1992 | A |
5180373 | Green | Jan 1993 | A |
5303602 | Morgan | Apr 1994 | A |
5753825 | Brandt, Jr. | May 1998 | A |
5794612 | Wachter | Aug 1998 | A |
5817950 | Wiklund | Oct 1998 | A |
5969266 | Mahoney | Oct 1999 | A |
6044716 | Yamamoto | Apr 2000 | A |
6129113 | Van Becelaere | Oct 2000 | A |
6164143 | Evans | Dec 2000 | A |
6430996 | Anderson | Aug 2002 | B1 |
6470755 | Beachey | Oct 2002 | B1 |
7454267 | Bonney | Nov 2008 | B2 |
7478565 | Young | Jan 2009 | B2 |
7561056 | McMillan | Jul 2009 | B2 |
7779834 | Calluaud et al. | Aug 2010 | B2 |
20030205229 | Crockford | Nov 2003 | A1 |
20030234015 | Bruce | Dec 2003 | A1 |
20040144383 | Thomas | Jul 2004 | A1 |
20060021620 | Calluaud | Feb 2006 | A1 |
20070163598 | Chang | Jul 2007 | A1 |
20070261498 | Orr | Nov 2007 | A1 |
20080092898 | Schneider | Apr 2008 | A1 |
20090139517 | Wachtel | Jun 2009 | A1 |
20110079220 | Altobelli | Apr 2011 | A1 |
20110270541 | Cha | Nov 2011 | A1 |
20120291781 | Kaufmann | Nov 2012 | A1 |
20150191884 | Aughton | Jul 2015 | A1 |
Entry |
---|
International Search Report dated Nov. 7, 2014 in the corresponding International Patent Application No. PCT/CA2014/000660. |
Number | Date | Country | |
---|---|---|---|
20160213865 A1 | Jul 2016 | US |